2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)

Osteoporosis

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis

Osteoporos Int.

Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, Meier C

doi: 10.1007/s00198-018-4794-0.

Osteoporosis

Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project

Swiss Med Wkly.

Morell S, Hemmeler C, Amsler F, Gross T

doi: 10.4414/smw.2017.14451

Osteoporosis

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

JAMA.

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Pignone M, Silverstein M, Simon MA, Tseng CW, Wong JB

doi: 10.1001/jama.2018.7498.

Osteoporosis

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Ann Intern Med.

Qaseem A, Forciea MA, McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians

doi: 10.7326/M15-1361.

Osteoporosis

Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis

JAMA Intern Med.

Cummings SR, Lui LY, Eastell R, Allen IE

doi: 10.1001/jamainternmed.2019.2779.

Osteoarthritis

Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

Lancet Diabetes Endocrinol.

Black DM, Bauer DC, Vittinghoff E, Lui LY, Grauer A, Marin F, Khosla S, de Papp A, Mitlak B, Cauley JA, McCulloch CE, Eastell R, Bouxsein ML, Foundation for the National Institutes of Health Bone Quality Project

doi: 10.

Osteoporosis

Fracture risk following intermission of osteoporosis therapy

Osteoporos Int.

Dennison EM, Cooper C, Kanis JA, Bruyère O, Silverman S, McCloskey E, Abrahamsen B, Prieto-Alhambra D, Ferrari S, IOF Epidemiology/Quality of Life Working Group.

doi: 10.1007/s00198-019-05002-w.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Semin Arthritis Rheum.

Romero-Bueno F, Diaz Del Campo P, Trallero-Araguás E, Ruiz-Rodríguez JC, Castellvi I, Rodriguez-Nieto MJ, Martínez-Becerra MJ, Sanchez-Pernaute O, Pinal-Fernandez I, Solanich X, Gono T, Gonzalez-Gay MA, Plana MN, Selva-O'Callaghan A, MEDRA5 (Spanish MDA5 Register) group (listed contributors at the end of the article)

doi: 10.1016/j.semarthrit.

Osteoporosis

Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study

doi: 10.1007/s00198-019-05270-6.

Related content

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis

Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians

Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis

Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

Fracture risk following intermission of osteoporosis therapy

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study